Rising Diabetes Rates Are Costly For Employers

Rising Diabetes Rates Are Costly for Employers

Rising Diabetes Rates Are Costly for Employers

Type 2 diabetes, characterized by high blood sugar and insulin resistance, and linked to unhealthy diets and a lack of regular exercise, is increasing among U.S. adults. That translates into high costs for employers—more than $20 billion annually due to unplanned, missed days of work.
The Cost of Diabetes in the U.S.: Economic and Well-Being Impact, a new report by Gallup researchers and Sharecare, a health and wellness engagement firm, was released to coincide with World Diabetes Day on Nov. 14.
November is also recognized by the Centers for Disease Control and Prevention, among others, as National Diabetes Month, a time for promoting awareness about managing diabetes.
(Click on graphic to view in a separate window.)
Being obese (severely overweight) is a leading risk factor for developing diabetes, the report noted. People with diabetes have much higher rates of other chronic disease such as high blood pressure, high cholesterol, heart attack and depression, and they are less likely to get regular exercise or engage in other healthy behaviors.
The findings are based on a subset of 354,473 telephone interviews with U.S. adults across all 50 states and the District of Columbia, conducted from January 2015 through December 2016 as part of the Gallup-Sharecare Well-Being Index. Diabetes cost analysis findings were drawn from research by the American Diabetes Association.
"While most clinicians agree that managing diabetes improves health and reduces medical costs, the benefit to employers also extends to a more productive workforce," said Sharecare Vice President Sheila Hol Continue reading

Rate this article
Total 1 ratings
Diabetes as a Disease of Fat Toxicity

Diabetes as a Disease of Fat Toxicity

The reason people get results with low-carb high fat diet is because of the minimal effects on insulin fat provides. There is no 2 ways around it. The camp that is lying is the camp that promotes starchy and moderate to high carb as either a cure or a mean to prevent diabetes. It’s all completely just wrong.
Put it this way, you ever heard of the term “if it ain’t broke don’t fix it”? Well there is a reason the primary and go-to cure from nearly every doctor (including the mainstream western doctors) is low-carb & high fat.
The other issue is, there was a person here who wrote up a decent little spiel on how insulin and diabetes go hand in hand. It got tons of likes, and consequently the mods of this forum pulled it, because I guess it “didn’t agree” with their views. Therein lies the problem, they don’t want people to know the truth for some odd reason.
I’ll break it down in a nutshell:
Type 1 Diabetes: Insulin dependent. People are usually born with this or acquire it at a very young age. These people are usually paper thin. They need to take insulin so they can in fact store their nutrients, otherwise they starve and die.
Type 2 Diabetes: Insulin Resistant – People acquire this through bad diet and partly (possibly) pre-disposed to it at birth making them a little more likely to get it if they aren’t careful. Insulin resistant is at it sounds, the body (or cells in this case) are resistant to the insulin the body produces.
So the question is, why? Well when you think of insulin as some annoying dude who continually knocks at the door, and your ins Continue reading

Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls

Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls

In type-2 diabetes, both insufficient insulin and excessive glucagon secretion contribute to hyperglycemia. We compared insulin, glucagon and somatostatin stores in pancreas obtained at autopsy of 20 lean and 19 obese non-diabetic (ND), and 18 type-2 diabetic (T2D) subjects. From concentrations and pancreas weight, total content of hormones was calculated. Insulin content was 35% lower in T2D than ND subjects (7.4 versus 11.3 mg), whereas glucagon content was similar (0.76 versus 0.81 mg). The higher ratio of glucagon/insulin contents in T2D was thus explained by the decrease in insulin. With increasing BMI of ND subjects, insulin and glucagon contents respectively tended to increase and decrease, resulting in a lower glucagon/insulin ratio in obesity. With aging, insulin and glucagon contents did not significantly change in ND subjects but declined in T2D subjects, without association with the duration of diabetes or type of treatment. The somatostatin content was lower in T2D than ND subjects (0.027 versus 0.038 mg), but ratios somatostatin/insulin and somatostatin/glucagon were not different. In conclusion, insulin stores are about 1/3 lower in T2D than ND subjects, whereas glucagon stores are unchanged. Abnormal secretion of each hormone in type-2 diabetes cannot be attributed to major alterations in their pancreatic reserves.
Glucose homeostasis mainly relies on the opposite hypoglycemic and hyperglycemic properties of insulin and glucagon. In type-2 diabetic (T2D) subjects, hyperglycemia is largely the consequence of insufficient insulin secretion and excessive glucag Continue reading

Diabetes and Sleep Apnea: What You Need To Know

Diabetes and Sleep Apnea: What You Need To Know

Do you snore? Do you feel fatigued every day? Do you wake up frequently throughout the night? It may be that the shallow breathing or breaks in breathing caused by sleep apnea are the reason. If you have diabetes, it is critical to manage your sleep apnea in order to manage your diabetes. Some 18 million Americans are diagnosed with sleep apnea, but millions more have it and don’t know it.
If you have diabetes, sleep apnea can make it almost impossible for you to manage your diabetes. This is because sleep apnea causes a pause in your breathing while you sleep and increases carbon dioxide in your blood, which leads to:
Insulin resistance so that the body doesn’t use insulin effectively. This causes more sugar in the blood stream leading to high blood sugars
Chronic elevated blood pressure
A higher incidence of heart problems or cardiovascular disease
Early morning headaches
Inadequate rest or sleep can also lead to lack of motivation to exercise or plan meals. This often leads to irritability, which can affect relationships with family, friends and coworkers. Sleepiness also can cause people to forget to take their medications and lead to further diabetes complications.
Sleep apnea may be genetically linked and it is most commonly found in those who are overweight or obese, people who smoke and are over the age of 40.
Could you have an obstruction?
There are different types of sleep apnea, one of which is obstructed sleep apnea (or OSA), which is when breathing is interrupted by a physical block to airflow. With OSA, snoring is common. The National Institutes of Health Continue reading

Differential Weight Loss Effects on Type 2 Diabetes Remission Among Adults

Differential Weight Loss Effects on Type 2 Diabetes Remission Among Adults

An analysis of nationally representative survey-based data finds that 5.2% of adults with type 2 diabetes were in remission, without bariatric surgery, at the end of the second year.
INTRODUCTION: Little is known about the variation in the effect of nonsurgical weight loss among obese and nonobese individuals on the incidence of type 2 diabetes (T2D) remission.
METHODS: Using data from a nationally representative healthcare survey, we analyzed the differential effect of weight loss on the relationship between obesity and the incidence of T2D remission over the span of 1 year among 3755 adults. Anyone who reported having T2D in the first year, but not in the subsequent year, was considered to be in remission. Changes in a person’s weight were measured as change in the body mass index. Data gathered between 2009 and 2013 were analyzed in 2016.
RESULTS: The incidence of self-reported remission was 5.22% (P <.001). Among obese individuals (BMI≥30), those who experiences a 3% drop in weight, at minimum, were 2.1 percentage points more likely to report remission than those who lost less than 3% bodyweight (P <.05). Comparing all individuals who lost more than 3% of their weight with those who lost less than 3% of their weight, obese individuals were 3.7 percentage points more likely than nonobese individuals to report being in remission (P <.05). Furthermore, after accounting for demographic and clinical information, we found that T2D remission was negatively associated with the duration of a T2D diagnosis and diabetes medication type, and was positively associated with being Continue reading

No more pages to load

Popular Articles

  • 'Alarming' rise in cancer rates driven by diabetes, obesity

    New research crunches the numbers on diabetes- and obesity-related cancers and projects a steep rise in diagnosed cases. Researchers at several institutions worldwide — including Imperial College London in the United Kingdom and the International Agency for Research on Cancer of the World Health Organization (WHO) in Lyon, France — have recently established that cancers related to metabolic di ...

  • Diabetes Rates Rise Among US Youth, Especially Minorities

    The gap in disease incidence among ethnic groups demands a policy response, say experts who weighed in on the SEARCH data. Results from the first decade a major study by the CDC and the National Institutes of Health (NIH) show diabetes incidence is rising rapidly among US youth, but especially among racial and ethnic minorities. The findings from the Search for Diabetes in Youth Study (SEARCH), wh ...

  • Poor Diet Linked to Heart Disease and Type 2 Diabetes Mortality Rates

    "You are what you eat" is a phrase that we have heard for years and years. Although this message may be stale at this point, it does make sense logically. Without nourishment, we could not survive. The types of food we eat and don't eat can play a role in our energy, mood, sleep, and overall well-being. Food is such an essential part of living that, over time, our daily choices can influence healt ...

  • Understudied racial minority groups show alarmingly high rates of obesity and diabetes

    RIVERSIDE, Calif. – Some of the smallest and historically neglected racial groups in the United States experience far more obesity, diabetes, and other health conditions than non-Hispanic white adults, a study by researchers at the University of California, Riverside has found. Using data for nearly 185,000 adults from the California Health Interview Survey (CHIS), the study reports that multira ...

  • High rates of scanning with Abbott′s FreeStyle Libre system linked to improved glucose control in diabetes patients

    Abbott today announced the results of real-world use data showing that people who scan more frequently using Abbott′s FreeStyle® Libre system spend less time in hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) while having improved average glucose levels. According to the data, more than 50,000 people with diabetes using the FreeStyle Libre system checked their glucose level ...

  • Strategies for Stabilizing Insulin Absorption Rates

    Strategies for Stabilizing Insulin Absorption Rates Last week, I introduced the topic of insulin absorption . I laid out the basics, and then gave a nice, cheery list of all the things that can go wrong with how our bodies handle incoming insulin. This week, well revisit that list and talk about some strategies for managing this issue. The first issue we went over last week was site selection. ...

  • American Diabetes Association® Releases 2018 Standards of Medical Care in Diabetes, with Notable New Recommendations for People with Cardiovascular Disease and Diabetes

    ARLINGTON, Va., Dec. 8, 2017 /PRNewswire/ -- Notable new recommendations in the 2018 edition of the American Diabetes Association's (ADA's) Standards of Medical Care in Diabetes (Standards of Care) include advances in cardiovascular disease risk management including hypertension; an updated care algorithm that is patient-focused; the integration of new technology into diabetes management; and rout ...

  • Leeds diabetes clinical champion raises awareness of gestational diabetes for World Diabetes Day

    In the lead up to World Diabetes Day (WDD) on 14 November, Clair Ranns, a Pharmacist at NHS Leeds Clinical Commissioning Groups (CCGs) Partnership, is raising awareness of a type of diabetes that affects pregnant women. Clair Ranns, Pharmacist at NHS Leeds CCGs Partnership and a Clinical Champion for Diabetes UK, said: “With this year’s WDD we’re raising awareness of gestational diabetes in ...

  • Diabetes doctors: Which specialists treat diabetes?

    Diabetes is a condition that affects a person's blood sugar levels and can require various treatments. Understanding which doctors help treat diabetes can simplify the process, making it less stressful. This article helps people with diabetes to understand the key differences between the various diabetes specialists. It also covers some common guidelines to follow for visiting each of these expert ...

Related Articles